A single disulfide bond differentiates aggregation pathways of beta2-microglobulin

Yiwen Chen1, Nikolay V Dokholyan

  • 1Department of Physics and Astronomy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Insights

The disulfide bond in beta2-microglobulin (beta2m) dictates its amyloid aggregation pathway. Oxidized beta2m forms domain-swapped dimers, while reduced beta2m forms flexible filaments, impacting hemodialysis complications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Chemistry

Background:

  • Beta2-microglobulin (beta2m) amyloidosis is a complication in hemodialysis patients.
  • The Cys25-Cys80 disulfide bond influences beta2m's native structure and aggregation propensity.

Purpose of the Study:

  • To elucidate the molecular mechanisms differentiating oxidized and reduced beta2m aggregation.
  • To compare the oligomerization pathways of beta2m under distinct redox conditions.

Main Methods:

  • Molecular dynamics simulations of beta2m oligomerization.
  • Analysis of protein structures under oxidized and reduced states at acidic pH.

Main Results:

  • Oxidized beta2m forms domain-swapped dimers, exchanging N-terminal segments.
  • Reduced beta2m forms parallel beta-sheet dimers and trimers, facilitating further aggregation.
  • Both oxidized and reduced dimers are less stable than monomers, suggesting aggregation is not driven by dimer stability.

Conclusions:

  • The Cys25-Cys80 disulfide bond dictates distinct beta2m aggregation pathways.
  • Domain swapping drives oxidized beta2m aggregation, while parallel stacking of unfolded monomers drives reduced beta2m aggregation.
  • Understanding these pathways may inform strategies to mitigate beta2m amyloidosis.

Related Concept Videos

Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Protein Folding01:22

Protein Folding

Overview
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...